Protocol Design Featured Articles
-
The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now?
8/16/2024
After the recent FDA rejection of MDMA-assisted therapy for PTSD, psychedelic drug developers and mental health experts alike are asking (and answering), "Where do we go now?"
-
Creating More Equitable Clinical Trials With Health Systems Science
8/15/2024
Belmont University Center for Health Systems Science Chair Douglas P. Slakey, MD, MPH explains how using health systems science to inform clinical trial design, implementation, and interpretation is crucial for achieving more equitable and effective patient outcomes.
-
Why Are Lupus Clinical Trials So Challenging?
8/13/2024
Lupus Therapeutics' Stacie Bell, Ph.D. explains why lupus clinical trials are challenging and what can be done to improve their overall success for patients in need.
-
Automation: From Protocol Definition To Submission
8/12/2024
Three members of Merck's global clinical data integration team discuss how automating various parts of the clinical trial process can improve data integrity.
-
Diversity Action Plan (DAP): Creating An Ecosystem For Success
8/12/2024
In part one of this two-part series, Elevate Advocacy Founder Devra Densmore explores how to create an ecosystem in which a successful diversity action plan (DAP) can be written and executed.
-
A Perfect Pair? Combining Keytruda And mRNA Therapy To Optimize Bladder Cancer Outcomes
8/7/2024
AdventHealth's Guru Sonpavde, MD credits the patient-centric trial design, the city’s diversity, and the staff’s expertise with executing the trial for giving bladder cancer patients a chance at a quicker and fuller recovery.
-
Key Considerations When Choosing A Central Laboratory Partner
7/30/2024
Central labs are pivotal in clinical research, offering a unified approach to sample processing and data management. Discover how these specialized facilities enhance trial efficiency and accuracy.
-
5 Drivers Of Patient Financial Toxicity — And 10 Tips To Address Them
7/30/2024
Clinical research administrator Tina Bowdish points to five causes of financial toxicity for patients participating in clinical trials and offers 10 ways to address them.
-
Another One For Ozempic? Investigator Recounts Trial For Chronic Kidney Disease
7/24/2024
Clinical Leader chatted with Richard E. Pratley about his positive experience working with Novo Nordisk on an Ozempic trial and the challenges of executing it amid the COVID-19 pandemic and changing standard-of-care landscape.
-
Top Countries For Rescuing Your Clinical Study
7/23/2024
When your study is in trouble, choosing the right country can help get it back on track. While many countries can and should be considered, palleos healthcare discusses the countries they have experienced with regard to clinical trial rescue.